Genotypic susceptibility score (GSS) and CD4+ T cell recovery in HIV-1 patients with suppressed viral load
Author(s) -
Alejandro GonzálezSerna,
Arie C. Glas,
Chanson J. Brumme,
Art F. Y. Poon,
Adriaóhpal De La Rosa,
Tania Mudrikova,
Viviane D. Lima,
Annemarie M. J. Wensing,
Richard Harrigan
Publication year - 2016
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkw455
Subject(s) - viral load , regimen , human immunodeficiency virus (hiv) , antiretroviral therapy , medicine , genotype , immunology , biology , virology , genetics , gene
HIV drug resistance, measured by the genotypic susceptibility score (GSS), has a deleterious effect on the virological outcome of HIV-1-infected patients. However, it is not known if GSS retains any predictive value for CD4 recovery in patients with suppressed viral load.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom